ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Indrayani Biotech announced its Rights Issue of up to 3.25 crore partly paid-up equity shares at ₹15 per share, aggregating to ₹48.79 Crore.
Indrayani Biotech Ltd has revised the schedule for its rights issue. The issue will now be open from September 15, 2026, to October 14, 2026.
Indrayani Biotech Ltd announced the resignation of Mr. K. Ravichandran as its Secretarial Auditor, effective August 6, 2026. The company will appoint a successor in due course.
Indrayani Biotech received approval from the Registrar of Companies to extend the deadline for its FY 2025-26 Annual General Meeting by two months, until November 30, 2026.
Indrayani Biotech Ltd reported revenue from operations of ₹37.8 Cr (-25.3% YoY) and net profit of ₹1 Cr for Q4 FY26.
Indrayani Biotech Ltd reported revenue from operations of ₹72.8 Cr (+43.9% YoY) and net profit of ₹1.1 Cr for Q4 FY26.
Indrayani Biotech Ltd has scheduled a Board of Directors meeting for August 17, 2026, to consider and approve the audited financial results for the year ended March 31, 2026.
A quarterly shareholding pattern filing by Indrayani Biotech Ltd for the period ending June 30, 2026.
Indrayani Biotech announced that the Income Tax Appellate Tribunal quashed a prior assessment order. The matter is restored to the First Appellate Authority for fresh adjudication.